Podcast Video: The REAL Story Of Ozempic, Weight Loss, And The Metabolic Crisis 94% Of Us Are Facing - Dr. Casey Means on The Liz Moody Podcast
You can also to this on Apple Podcasts and Spotify. Read the full podcast transcript here.
Leading metabolic health doctor & researcher Casey Means, MD, discusses how GLP-1 receptor agonists like Ozempic & Wegovy work, the differences between obesity and metabolic health, how to avoid metabolic dysfunction, and much more.
In this episode of the Liz Moody podcast, host Liz Moody delves into the hot topic of Ozempic, weight loss, and the underlying metabolic crisis in America. Dr. Casey Means, a leading metabolic health expert, co-founder of Levels, and author of New York Times best-selling book Good Energy, provides a science-based, nuanced perspective on these issues. They discuss the distinction between obesity and metabolic health, the influence of modern lifestyles on metabolic dysfunction, and the holistic approaches needed to improve metabolic health without relying solely on medications like Ozempic. The conversation also explores practical strategies to enhance mitochondrial function, such as dietary adjustments, movement, and reducing exposure to toxins.
What they discuss:
The Obesity and Metabolic Health Debate
Understanding Different Types of Fat: Subcutaneous, Visceral, and Intracellular
Ozempic's Impact on Metabolic Health
Mitochondria and Metabolic Health
The Eight Pillars Affecting Mitochondria
Ozempic: Mechanisms and Physical Effects
Natural Ways to Boost GLP-1 and Inhibit DPP-4
The Food Industry and Cravings
The Consequences of Obesity and the Healthcare System
Personal Responsibility vs. Systemic Forces
The Impact of Policy on Health
Understanding Metabolic Health
Tracking Biomarkers for Better Health
Addressing Hidden Health Issues
The Importance of Movement vs Exercise
The Dangers of Ultra-Processed Foods
The Root Cause of Health Issues
